Mutual of America Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-86,576
Closed -$4.47M 1627
2022
Q3
$4.47M Sell
86,576
-7,874
-8% -$325K 0.06% 459
2022
Q2
$2.34M Sell
94,450
-41,248
-30% -$909K 0.03% 808
2022
Q1
$3.4M Sell
135,698
-5,902
-4% -$166K 0.04% 735
2021
Q4
$5.16M Buy
141,600
+22,200
+19% +$779K 0.05% 534
2021
Q3
$2.04M Buy
119,400
+68,764
+136% +$1.07M 0.02% 947
2021
Q2
$678K Sell
50,636
-2,177
-4% -$53.6K 0.01% 1107
2021
Q1
$2.71M Sell
52,813
-2,917
-5% -$175K 0.03% 833
2020
Q4
$3.45M Buy
55,730
+10,172
+22% +$582K 0.04% 668
2020
Q3
$2.5M Sell
45,558
-7,793
-15% -$420K 0.03% 714
2020
Q2
$3.07M Buy
+53,351
New +$2.9M 0.04% 596

Other funds holding CCXI

Mutual of America Capital Management's CCXI Position: Q4 2022 in Review

Mutual of America Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 86,576 shares — an estimated $4.47M sold.

Mutual of America Capital Management first reported a position in CCXI in Q2 2020 and held it in 10 quarters. The position peaked at $5.16M in Q4 2021. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Mutual of America Capital Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 86,576 ChemoCentryx, Inc. shares in Q4 2022, an estimated $4.47M.
  • Mutual of America Capital Management first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 10 quarters.
  • Mutual of America Capital Management's ChemoCentryx, Inc. position peaked at $5.16M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.